Envoy Medical Inc. (NASDAQ:COCH) — Market Cap & Net Worth
Market Cap & Net Worth: Envoy Medical Inc. (COCH)
Envoy Medical Inc. (NASDAQ:COCH) has a market capitalization of $52.51 Million ($52.51 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21819 globally and #4880 in its home market, demonstrating a -1.46% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Envoy Medical Inc.'s stock price $0.68 by its total outstanding shares 77194595 (77.19 Million). Also see COCH total asset value for a full breakdown of the balance sheet.
Envoy Medical Inc. Market Cap History: 2021 to 2026
Envoy Medical Inc.'s market capitalization history from 2021 to 2026. Data shows change from $751.88 Million to $52.51 Million (-39.00% CAGR). Also see COCH cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Envoy Medical Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #630 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #2084 of 3165 |
Weight: Envoy Medical Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Envoy Medical Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Envoy Medical Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check COCH share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
211.76x
Envoy Medical Inc.'s market cap is 211.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $751.88 Million | $310.00K | -$8.68 Million | 2425.40x | N/A |
| 2022 | $773.49 Million | $237.00K | -$15.92 Million | 3263.67x | N/A |
| 2023 | $139.80 Million | $316.00K | -$29.92 Million | 442.40x | N/A |
| 2024 | $110.39 Million | $225.00K | -$20.80 Million | 490.61x | N/A |
| 2025 | $51.03 Million | $241.00K | -$23.76 Million | 211.76x | N/A |
Competitor Companies of COCH by Market Capitalization
Companies near Envoy Medical Inc. in the global market cap rankings as of September 18, 2026. Review Envoy Medical Inc. tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Envoy Medical Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Envoy Medical Inc. Historical Marketcap From 2021 to 2026
Between 2021 and today, Envoy Medical Inc.'s market cap moved from $751.88 Million to $ 52.51 Million, with a yearly change of -39.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $52.51 Million | +2.89% |
| 2025 | $51.03 Million | -53.77% |
| 2024 | $110.39 Million | -21.04% |
| 2023 | $139.80 Million | -81.93% |
| 2022 | $773.49 Million | +2.87% |
| 2021 | $751.88 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Envoy Medical Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.51 Million USD |
| MoneyControl | $52.51 Million USD |
| MarketWatch | $52.51 Million USD |
| marketcap.company | $52.51 Million USD |
| Reuters | $52.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Envoy Medical Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseoin… Read more